Linaglip M 2.5/1000 ER mg is a combination oral antidiabetic medication that brings together Linagliptin 2.5 mg (a DPP-4 inhibitor) and Metformin Hydrochloride 1000 mg (Extended Release) to provide effective, once-daily control of blood glucose levels in adults with type 2 diabetes.
This formulation is designed to complement a healthy lifestyle, diet, and exercise plan, helping patients maintain long-term glycemic control with minimal daily dosing.